Biologic drugs, often made with the help of living organisms, are especially lucrative because they have scant competition from biosimilars, drugs akin to generics. It's a different story in Europe.
Read more on NPR
Wednesday, 19 December 2018
loobobilly News: Why The U.S. Remains The Most Expensive Market For 'Biologic' Drugs In The World
Labels:
Business
,
loobobillyNPR
Biologic drugs, often made with the help of living organisms, are especially lucrative because they have scant competition from biosimilars, drugs akin to generics. It's a different story in Europe.
Read more on NPR
Do You Like This Article
Get Subscribe to Free Email Updates!!
Popular Posts
-
If you are a street dog ,a 🐶 lover 🦮a compassionate human 😘, and you want to support someone, then you have one simple way to help: subs...
-
govnanavernisuka : Realness 29TH SEPTEMBER 2016 REBLOGGED FROM GOVNANAVERNISUKA NOTES: 5163 svetlanak...
-
Peter Thiel, one of Donald J. Trump’s biggest donors in 2016, has re-emerged as a prime financier of the Make America Great Again movement. ...
-
The startup Fast is a hit in Silicon Valley. But its CEO raises eyebrows in Australia The payments startup Fast has raised tens of millions ...
-
Amazon labor push escalates as workers at New York warehouse win a union vote Amazon will face two union elections at once. Federal official...
-
Families of Sandy Hook victims reach settlement with Remington Families of victims killed in the Sandy Hook Elementary School shooting have ...
-
Why we'll probably see avocado prices rise soon in the U.S. Earlier this week, the U.S. Department of Agriculture put a temporary suspen...
